Posted in: Ingredient Buyer Guides
A formulation brief describes the finished product a team wants to develop. Ingredient requirements translate that brief into material identity, form, and functional attributes that product development and quality teams can review. This handoff helps a team ask more precise questions before it selects an ingredient or compares supplier offers.
It is a working document, not a claim that a material will deliver a finished-product result. Keep confirmed requirements separate from assumptions, and assign each open question to the person who can resolve it.
Build the supplement formulation brief
Record the intended dosage form, product type, target market, development stage, and known process conditions. Add only details that affect ingredient selection or evaluation. For example, a powder blend may raise questions about particle-size distribution or flow, while a liquid format may require the team to investigate dispersion or solubility. These are prompts for evaluation, not promises about a specific ingredient.
State the product’s intended use in neutral development language. Do not turn a formulation objective into an unsubstantiated health or performance claim, and do not infer a serving level from a supplier’s general application description.
Define identity before comparing materials
Write the ingredient name and the material form the project needs. Where relevant, distinguish a salt, hydrate, isomer, botanical species and plant part, extract, or carrier-containing preparation. Use identifiers only after the team verifies that they describe the intended substance and form.
For botanical ingredients, identify the accepted scientific name and plant part when confirmed. Record extract descriptors or marker requirements only when they are relevant to the product and supported by the project’s technical decision. A common name or trade name alone may not resolve identity.
If alternatives could work, list them separately and mark them for technical review. Combining different forms into one line can hide differences that matter to formulation, labeling, or quality assessment.
Convert process needs into evaluation questions
Describe the operation that could affect material selection: blending, compression, hydration, heating, granulation, or another relevant step. Identify the property the team needs to evaluate, such as flow, dispersibility, particle size, sensory impact, or compatibility with other components.
Where a target is not yet established, write it as an open question rather than inventing a numeric limit. Product development should define the test conditions and acceptance criteria with quality and regulatory reviewers. A supplier’s general statement does not establish performance in the buyer’s formula or process.
Separate requirements from assumptions
Use a short decision table during internal review:
| Topic | Record | Status |
|---|---|---|
| Ingredient identity and form | Required name and acceptable alternatives | Confirmed or open |
| Dosage form and process | Conditions that may affect material choice | Confirmed or open |
| Functional attributes | Property to evaluate and test context | Required, preferred, or open |
| Destination market | Market relevant to labeling and regulatory review | Confirmed or open |
| Evidence needed | Technical data or document the team needs to assess | Requested or pending |
| Decision owner | Product development, QA, regulatory, or procurement reviewer | Assigned or open |
This table organizes product-development decisions. It is not a universal raw-material specification or a substitute for a buyer’s quality system.
A practical brief-to-requirements worksheet
Before contacting a supplier, the project team can use the supplement formulation brief to make its request easier to evaluate. Mark each answer as confirmed, preferred, or still open.
| Brief field | What to capture | Example of a useful question |
|---|---|---|
| Finished-product format | Capsule, tablet, powder blend, liquid, or another intended format | Does the intended format impose handling or processing constraints? |
| Ingredient identity | Exact name and acceptable material forms | Is a specific salt, botanical part, or extract identity required? |
| Process context | Relevant blending, heating, hydration, or compression steps | Which process conditions should be considered during material review? |
| Material attributes | Properties the team wants to assess, without inventing limits | Is flow, dispersibility, particle size, or another attribute relevant? |
| Market and use context | Destination market and product category | Which regulatory reviewer should assess market-specific requirements? |
| Evidence requested | Documents or technical information needed for evaluation | Which document should QA review before a sample decision? |
| Quantity and timing | Development quantity, sample need, and target purchase window | What quantity and timing should procurement include in an RFQ? |
| Open decisions | Unresolved questions and the person responsible for answering them | Who owns the decision and when will it be reviewed? |
The example questions are prompts, not claims about GNB’s inventory, sample availability, MOQ, lead time, or documentation for any specific SKU. Confirm product-specific details on the matching product page or through the sales team.
Review by the right functions
Product development should confirm that the supplement formulation brief captures the intended formula context, material form, and process questions. Quality should determine which material attributes and evidence are needed for evaluation. Regulatory staff should assess the relevant destination market and organizational roles. Procurement can then carry the approved requirements into its sourcing process.
Requirements depend on the product, operation, market, and responsibilities of the parties. In the United States, 21 CFR Part 111 addresses current good manufacturing practice for covered dietary-supplement operations; it is not a universal ingredient-selection template. Qualified regulatory personnel should determine what applies to a specific project.
Move from requirements to sourcing

Once the product team has resolved or clearly marked its open technical questions, it can use the relevant GNB application overview to explore ingredient categories and review a matching product page for available product-specific information. The broader nutraceutical ingredient sourcing guide covers the subsequent supplier-evaluation workflow.
For a project that is ready for supplier review, send the ingredient identity, intended form, target application, estimated quantity, destination market, and unresolved specification questions through Request a Quote. Availability and commercial terms must be confirmed for the specific product and order.
Frequently asked questions
Is a formulation brief the same as an ingredient specification?
No. A formulation brief describes the intended finished product and its development context. Ingredient requirements identify the material and attributes the team needs to evaluate. A formal specification and its acceptance criteria require review by the responsible quality function.
Which details from a product brief matter for ingredient selection?
Include dosage form, relevant processing conditions, target market, and the material properties the team needs to investigate. Leave uncertain values open for the technical owners to define.
Should a team set numeric limits before contacting suppliers?
Set limits when the project has a justified technical basis and an accountable reviewer. Otherwise, state the property and test question, then agree the criteria through product-development and quality review. Do not copy limits from a different ingredient or historic lot.
Does 21 CFR Part 111 provide a universal ingredient template?
No. It is a U.S. regulation for covered dietary-supplement operations. Its applicability depends on the project and organizational roles; it should not be generalized to every ingredient supplier or export market.
References
- U.S. Electronic Code of Federal Regulations, 21 CFR Part 111. U.S.-specific source; applicability requires qualified review.





